EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Vena cava leiomyosarcoma surgery results in a retrospective cohort of 41 patients from two centers

Thibaud Bertrand, Matthieu Faron, Olaf Mercier, Carine Ngo, Cécile Le Pechoux, Antonin Levy, Justin Issard, Clémence Henon, Charles Honoré, Elie Fadel, Axel Le Cesne

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27765 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Thibaud Bertrand und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Gustave Roussy Cancer Campus, Villejuif, France. Hauptthemen laut MEDLINE: Leiomyosarcoma, Vena Cava, Inferior, Vascular Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Leiomyosarcoma of the vena cava (LMS‐VC) is a rare entity with poor oncological outcomes and a lack of histological staging prognostic factors.

Methods

Outcomes of consecutive patients operated on LMS‐VC between March 2003 and May 2022, in two specialized sarcoma centers were reported.

Result

Forty‐one patients were identified. Median size of LMS‐VC was 9 cm with 68% of complete obstruction. After surgery, severe complication rate was 30%. No postoperative mortality was reported. Microscopic complete excision was obtained for 71% of patients, R1 for 27% and one patient presented an R2 resection. Grade 3 was found in 24%. After a median follow‐up of 70 months, 3 years disease‐free survival (DFS) and 5 years DFS were 34% and 17%, and 3 years overall survival (OS) and 5 years OS were 74% and 50%. Distant metastasis concerned 54% of recurrences, local 7% and local and distant 5%. Multivariate analysis showed that FNCLCC grade ( p < 0.001) and perioperative chemotherapy ( p = 0.026) were significant factors for DFS. In multivariate analysis, FNCLCC grade was a significant factor for OS ( p = 0.004).

Discussion

Perioperative chemotherapy may have a role to play in lowering the risk of recurrence for LMS‐VC, particularly in high‐grade tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyosarcomaVena Cava, InferiorVascular NeoplasmsHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultSurvival RateFollow-Up StudiesPrognosisNeoplasm Recurrence, LocalAged, 80 and over

Stichwörter der Autor:innen

LMSinferior vena cavaleiomyosarcomaoutcomesprimaryprognosticsuperior vena cava

Autor:innen und Institutionen

  • Department of Surgical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • INSERM 1018, CESP, Equipe ONCOSTAT, Université Paris Saclay, Villejuif, France.
  • Department of Thoracic Surgery and Heart-Lung Transplantation Marie-Lannelongue Hospital, GHPSJ, Le Plessis Robinson, France.
  • Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Radiation Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
  • INSERM 1030, Molecular Radiotherapy and Therapeutic innovations, Université Paris Saclay, Villejuif, France.

Zitieren

APA

Bertrand, T., Faron, M., Mercier, O., Ngo, C., Le Pechoux, C., Levy, A., Issard, J., Henon, C., Honoré, C., Fadel, E., & Le Cesne, A. (2024). Vena cava leiomyosarcoma surgery results in a retrospective cohort of 41 patients from two centers. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27765

Vancouver

Bertrand T, Faron M, Mercier O, Ngo C, Le Pechoux C, Levy A, et al. Vena cava leiomyosarcoma surgery results in a retrospective cohort of 41 patients from two centers. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27765

BibTeX
@article{Bertrand2024,
  author = {Bertrand, Thibaud and Faron, Matthieu and Mercier, Olaf and Ngo, Carine and Le Pechoux, Cécile and Levy, Antonin and Issard, Justin and Henon, Clémence and Honoré, Charles and Fadel, Elie and Le Cesne, Axel},
  title = {Vena cava leiomyosarcoma surgery results in a retrospective cohort of 41 patients from two centers},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27765}
}
Kostenlos starten →